Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Calyx Bio-Ventures' subsidiary Cannigistics Agri-Solutions (Cannigistics) has entered into a memorandum of understanding (MOU) with an unnamed third party group of Canadian medical specialists with respect to the implementation of a clinical trials software platform.
Subscribe to our email newsletter
The Canadian group will use Cannigistics’ software and information technology platform to gather, store, analyze and report on the results of the trials.
This technology platform will help in creating an environment that will allow the physicians to conduct the trials with confidence.
The secured data can be used, parsed, sorted, analyzed and made anonymous so that other specialists can also have access to the results with no concerns over patient confidentiality.
According to the company, the resulting platform will be a tailor made solution licensed on a non-exclusive basis, allowing it to license the resulting platform to any other parties conducting clinical trials with the ability to customise to their specific needs.
Cannigistics president and CEO Roger Forde said: "We are pleased to have entered into an agreement with a respected group of healthcare practitioners to provide an end-to-end technical solution, from application design to deployment and management.
"This further validates the strategy that Cannigistics has established to provide technology solutions addressing key requirements of companies operating in the health sciences sector. We are looking forward to becoming a significant participant in the sector."